🇺🇸 ILMN — Illumina, Inc.

Salud Mantener
← Volver

Precio actual

238,21 USD

Máx. histórico

510,54

1905 días

Split 1028:1000 del 25/06/2024

Caída desde máximo

-53,34%

Rango 52 semanas

112,65 – 309,35

Variación hoy

+5,13%

Cierre anterior

226,58

Rango de hoy

229,08 – 241,85

Volumen hoy

2.212.282

Peor caída histórica

-96,14%

01/09/2000 → 13/03/2003

Recuperado en 1595 días

Volatilidad anualizada ⓘ

56,40%

Información
Nombre completo
Illumina, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Diagnostics & Research
Empleados
8.600
PER ⓘ
44,44 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
261,60 USD (puede no estar actualizado)
Primera cotización
28/07/2000
Precio actualizado
hace 13 horas
Sobre la empresa

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2024 1028:1000
23/09/2008 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 124,88 128,00 122,39 126,60 +1,89% 4,49% 2.926.305
15/03/2024 124,03 125,05 122,84 124,25 -0,29% 1,78% 2.302.206
14/03/2024 128,35 129,57 122,76 124,61 -3,52% 5,31% 1.477.956
13/03/2024 128,40 131,92 128,02 129,16 +0,05% 3,04% 1.634.417
12/03/2024 135,16 135,16 129,01 129,10 -4,57% 4,55% 2.193.855
11/03/2024 132,59 136,40 131,83 135,27 +2,68% 3,45% 1.380.193
08/03/2024 133,49 136,03 130,62 131,74 -0,42% 4,05% 1.976.227
07/03/2024 133,09 134,99 131,61 132,30 +0,64% 2,54% 1.180.555
06/03/2024 132,60 133,45 129,75 131,45 +0,33% 2,80% 1.213.246
05/03/2024 132,49 133,65 130,76 131,01 -2,19% 2,18% 1.472.302
04/03/2024 136,43 136,97 132,22 133,95 -1,99% 3,48% 1.517.739
01/03/2024 135,41 138,81 131,78 136,67 +0,48% 5,19% 1.951.864
29/02/2024 140,05 142,10 135,97 136,02 -0,82% 4,38% 1.260.636
28/02/2024 134,55 139,27 134,36 137,14 +0,87% 3,65% 1.213.862
27/02/2024 133,30 136,24 131,12 135,95 +2,04% 3,84% 1.359.838
26/02/2024 131,33 135,86 131,32 133,24 +2,98% 3,45% 2.106.269
23/02/2024 132,07 132,89 129,29 129,38 -1,88% 2,73% 1.358.913
22/02/2024 133,60 133,67 130,50 131,86 -0,63% 2,37% 2.158.903
21/02/2024 133,75 135,35 130,22 132,69 -2,60% 3,83% 1.571.812
20/02/2024 137,86 139,01 134,82 136,24 -2,34% 3,03% 1.401.370
16/02/2024 140,24 143,24 138,81 139,50 -1,82% 3,16% 1.930.687
15/02/2024 138,30 143,00 137,16 142,09 +3,79% 4,22% 1.510.132
14/02/2024 131,34 137,11 130,37 136,91 +5,23% 5,13% 1.783.786
13/02/2024 132,77 134,20 126,10 130,10 -4,44% 6,10% 2.385.063
12/02/2024 134,09 136,50 131,62 136,15 +1,54% 3,63% 2.675.678
09/02/2024 139,83 143,68 131,61 134,09 -3,83% 8,63% 3.832.281
08/02/2024 138,59 140,90 135,40 139,43 +0,27% 3,97% 2.503.591
07/02/2024 141,14 141,14 136,10 139,05 -1,35% 3,57% 1.763.842
06/02/2024 138,23 142,14 137,36 140,94 +1,87% 3,46% 1.815.859
05/02/2024 139,01 139,37 137,49 138,36 -1,37% 1,35% 1.339.176